Go back
Covid-19 may have caused the loss of more than 20,5 million years of life worldwide
Barcelona, 19 February 2021
- Research with prominent participation by the Center for Research in Health and Economics (CRES-UPF) and the Max Planck Institute for Demographic Research, has calculated the years of life lost (YLL) rate due to the pandemic in 81 countries.
- In the study, published in the journal Scientific Reports, the researchers conclude that the YLL rate associated with covid-19 is between two to nine times higher than that attributable to seasonal flu, and that on average, for each death sixteen years are lost.
- Of the total years of life lost, 44.9% occurred in individuals between 55 and 75 years of age, 30.2% among people under 55, and 25% in the over 75s.
Related news
Mediterranean diet or mindfulness during pregnancy reduces the risk of a low birth weight baby
Researchers from BCNatal with the support of the ”la Caixa” Foundation has demonstrated for the first time a reduction of low birth weight babies up to 29% and 36%.
One Health: the holistic approach needed to tackle future pandemics
”la Caixa” Foundation and Biocat bring together the main experts in global health in a conference to discuss what they learned during Covid-19 and how to deal with upcoming pandemics.
The new ”la Caixa” Foundation - BIST Chemical Biology Programme launches a hub in Barcelona for the design of new drugs
The initiative aims to attract talent from the field of chemical biology, and to create an ecosystem that fosters research excellence in improving health.
More than 5.000 students and researchers have received a fellowship from ”la Caixa” Foundation
A total of 5.213 students and researchers have had the opportunity to train in the world’s best universities and research centres thanks to the exemplary fellowships awarded by ”la Caixa” Foundation.
Coronavirus Vaccines Stir Doubts Among Many People Worldwide, New Study Shows
Nature Medicine publishes findings of a 13,400-person survey in 19 countries hit hard by COVID-19.
New Study to Assess the Efficacy of Ivermectin Against COVID-19
Clínica Universidad de Navarra and the Barcelona Institute for Global Health launch a clinical trial to determine the efficacy of ivermectin in reducing viral replication after 7 days.
